IL-3/IL-5/GM-CSFR β Antibodies

Santa Cruz Biotechnology delivers a wide array of IL-3/IL-5/GM-CSFR β monoclonal antibodies for research focused on cytokine receptor functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IL-3, IL-5, and GM-CSF receptors are essential for hematopoiesis and immune regulation, playing significant roles in the proliferation and differentiation of hematopoietic cells. Dysregulation of IL-3/IL-5/GM-CSFR β pathways is implicated in various diseases, including asthma and other allergic conditions, making research in this area vital for developing targeted therapies. Understanding the signaling mechanisms of IL-3/IL-5/GM-CSFR β provides valuable insights into immune responses and potential therapeutic interventions. Researchers can explore receptor-ligand interactions, signal transduction pathways, and cellular responses using specific monoclonal antibodies. Investigating IL-3/IL-5/GM-CSFR β signaling pathways helps reveal their role in normal physiological processes and disease states. Santa Cruz Biotechnology monoclonal antibodies for IL-3/IL-5/GM-CSFR β support researchers worldwide in advancing immunology and cell biology discoveries.